<?xml version="1.0" encoding="UTF-8"?>
<p id="p0230">The incidence of GH is on the rise, bringing great pain to patients and causing increased rates of fetal abortion, permanent nerve injury, and neonatal malformation through placental transmission (
 <xref rid="bib54" ref-type="bibr">Schiffer and Gottlieb, 2017</xref>). At present, nucleoside drugs such as acyclovir, ganciclovir, and penciclovir are commonly used to treat HSV-2 infections. These drugs inhibit the viral DNA polymerase via triphosphorylation, affecting viral replication (
 <xref rid="bib3" ref-type="bibr">Benzekri et al., 2018</xref>). However, drug resistance rates are increasing, especially among immunosuppressed individuals (
 <xref rid="bib14" ref-type="bibr">Dai et al., 2018</xref>). There is currently no effective HSV-2 vaccine (
 <xref rid="bib11" ref-type="bibr">Churqui et al., 2018</xref>), so the exploration of natural plant pharmaceuticals and their active components has become a hot spot in the development of new antiviral drugs (
 <xref rid="bib31" ref-type="bibr">Kesharwani et al., 2017</xref>; 
 <xref rid="bib66" ref-type="bibr">Yildirim et al., 2016</xref>).
</p>
